Trials / Withdrawn
WithdrawnNCT04541576
The Merit WRAPSODY Central Feasibility Study
Prospective, Non-Randomized, Controlled, Multicenter Feasibility Study of the Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Central Venous Outflow Circuit Stenosis or Occlusion in Hemodialysis Patients
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Merit Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlusion within the dialysis access outflow circuit in the thoracic central veins
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Merit WRAPSODY Endovascular Stent Graft | Target lesion treated with stent graft placement |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2022-07-01
- Completion
- 2024-02-01
- First posted
- 2020-09-09
- Last updated
- 2021-04-20
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04541576. Inclusion in this directory is not an endorsement.